New: Introducing the Finviz Futures Map

Learn More
Last Close
Sep 10  •  04:00PM ET
6.48
Dollar change
+0.02
Percentage change
0.31
%
Index- P/E- EPS (ttm)-0.38 Insider Own59.88% Shs Outstand72.32M Perf Week22.50%
Market Cap468.63M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float29.01M Perf Month-
Enterprise Value511.02M PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-
Income-27.46M P/S154.66 EPS this Y- Inst Trans- Short Ratio- Perf Half Y-
Sales3.03M P/B- EPS next Y- ROA-202.39% Short Interest- Perf YTD41.18%
Book/sh-0.68 P/C679.18 EPS next 5Y- ROE- 52W High7.12 -8.99% Perf Year-
Cash/sh0.01 P/FCF- EPS past 3/5Y-36.87% - ROIC- 52W Low4.19 54.65% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y3.32% - Gross Margin-28.64% Volatility8.29% - Perf 5Y-
Dividend TTM- EV/Sales168.65 EPS Y/Y TTM80.41% Oper. Margin-497.72% ATR (14)0.83 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.04 Sales Y/Y TTM-45.90% Profit Margin-905.97% RSI (14)- Recom-
Dividend Gr. 3/5Y- - Current Ratio0.24 EPS Q/Q-142.27% SMA2012.21% Beta- Target Price-
Payout- Debt/Eq- Sales Q/Q-68.69% SMA5012.21% Rel Volume0.39 Prev Close6.46
Employees75 LT Debt/Eq- Earnings- SMA20012.21% Avg Volume3.45M Price6.48
IPOAug 29, 2025 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume1,352,279 Change0.31%
Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.